Ignite Creation Date:
2025-12-26 @ 4:02 PM
Ignite Modification Date:
2026-01-25 @ 6:57 AM
Study NCT ID:
NCT00349206
Status:
COMPLETED
Last Update Posted:
2014-04-10
First Post:
2006-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization: